Johnson & Johnson Announces Major US Investment Increase

In a significant move, Johnson & Johnson (J&J) has declared a 25% increase in its investments within the United States, totaling over $55 billion over the next four years. This marks a substantial rise from the previous four-year period.

Groundbreaking of High-Tech Facility in North Carolina

CEO Joaquin Duato highlighted the company's commitment to innovation and healthcare challenges by announcing the groundbreaking of a new high-tech facility in North Carolina. This initiative is part of J&J's nearly 140-year legacy of American innovation.

Expansion and Investment Across Multiple Sectors

Beyond the North Carolina facility, J&J is channeling funds into new advanced manufacturing facilities and expanding several existing sites across its Innovative Medicine and MedTech businesses. The company is also ramping up investments in research and development (R&D) infrastructure and technology, signaling a robust push towards future growth and innovation.